Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson’s disease

Autor: Sara Al-Sweidi, Marc Morissette, T. Di Paolo
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
Receptor
Metabotropic Glutamate 5

Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
Estrogen receptor
Biochemistry
Mice
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Internal medicine
medicine
Animals
Estrogen Receptor beta
Parkinson Disease
Secondary

Receptor
Molecular Biology
Estrogen receptor beta
Mice
Knockout

Estradiol
Metabotropic glutamate receptor 5
Brain-Derived Neurotrophic Factor
MPTP
Estrogen Receptor alpha
Glutamate receptor
Cell Biology
Corpus Striatum
Mice
Inbred C57BL

Disease Models
Animal

030104 developmental biology
Metabotropic receptor
nervous system
chemistry
1-Methyl-4-phenyl-1
2
3
6-tetrahydropyridine

Molecular Medicine
Estrogen receptor alpha
030217 neurology & neurosurgery
Zdroj: The Journal of Steroid Biochemistry and Molecular Biology. 161:84-91
ISSN: 0960-0760
Popis: Glutamate is the most important brain excitatory neurotransmitter and glutamate overactivity is well documented in Parkinson's disease (PD). Metabotropic glutamate (mGlu) receptors are reported to interact with membrane estrogen receptors (ERs) and more specifically the mGlu5 receptor subtype. 17β-estradiol and mGlu5 antagonists have neuroprotective effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. We previously reported that ERα and ERβ are involved in neuroprotection following MPTP toxicity. The present study investigated the implication of ERs on the mGlu5 receptor adaptive response to MPTP toxicity in the brain of wild type (WT), ER knockout (ERKO)α and ERKOβ male mice. Autoradiography of [(3)H]ABP688 specific binding to striatal mGlu5 receptors showed a dorsal/ventral gradient similar for WT, ERKOα and ERKOβ mice with higher values ventrally. The lateral septum had highest [(3)H]ABP688 specific binding that remained unchanged in all experimental groups. ERKOα and ERKOβ mice had similarly lower striatal [(3)H]ABP688 specific binding than WT mice as measured also by Western blots. MPTP dose-dependently decreased striatal [(3)H]ABP688 specific binding in WT but not in ERKOα and ERKOβ mice; this correlated positively with striatal dopamine concentrations. A 17β-estradiol treatment for 10 days left unchanged striatal [(3)H]ABP688 specific binding of unlesioned mice of the three genotypes. 17β-estradiol treatment for 5 days before MPTP and for 5 days after partially prevented the mGlu5 receptor decrease only in WT MPTP mice and this was associated with higher BDNF striatal contents. These results thus show that in male mice ERs affect striatal mGlu5 receptor levels and their response to MPTP.
Databáze: OpenAIRE